PET-MRI imaging test in lung cancer and lung disease
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in one of the study groups: healthy, lung cancer stage IIIA, idiopathic pulmonary fibrosis/interstitial lung disease, chronic lung transplant rejection (CLAD), or immune therapy–related pneumonitis.
- You must be able to sign informed consent and pass the study doctor’s health screening.
- If you smoke or recently smoked, you likely won’t qualify (no tobacco use in the prior 6 months for most groups).
- You must be able to have MRI/PET scans—meaning you can lie comfortably in the scanner without severe claustrophobia.
- You must avoid certain metal/electrical items (for example pacemakers, metal implants, metal clips, or metal tattoos).
- If you are pregnant or breastfeeding, you cannot join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether advanced MRI scans can better detect and track lung scarring in people with certain types of pulmonary fibrosis. It may help doctors understand how well your treatment is working, without extra radiation from CT scans.
This Phase 2 study tests a special PET scan tracer to help doctors spot tissue damage after radiation treatment in people with certain lung or pancreatic cancers. The goal is to improve detection and planning around chemoradiation and surgery.
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
This study tests a special PET scan that uses a new tracer to help see fibrosis (scarring) in the body. It may help doctors better understand and manage conditions like lung or liver fibrosis.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This Phase 1 study tests whether a specialized PET scan tracer can “light up” metastatic non-small cell lung cancer in the brain. If you join, you’ll get brain MRI and PET/CT scans and you’ll continue with your planned cancer treatments and follow-up imaging.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.